Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

11. Challenges of trials with new antibiotics: The view of the industry

    John Tomayko, Cambridge, United States

    07 September 2018

    Relevance:

     

    72%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Lisbon, Portugal
    Conference lecture

    New Antibacterial Agents & Stewardship

12. Drug-likeness: Physicochemical roperties in small-molecule drug iscovery

    Andrea Decker, Basel, Switzerland

    04 September 2018

    Relevance:

     

    69%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Lisbon, Portugal
    Conference lecture

    New Antibacterial Agents & Stewardship

13. Drug discovery within the context of AMR: extending beyond ‘me too’ drugs

    Tom Parr, Cambridge, MA, United States

    21 September 2016

    Relevance:

     

    69%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

14. Why target-based drug discovery has not been very successful

    Steve Baker, Collegeville, PA, United States

    21 September 2016

    Relevance:

     

    67%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

15. Getting drugs into Gram-negative bacteria

    Mathias Winterhalter, Bremen, Germany

    21 September 2016

    Relevance:

     

    67%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

16. The role of breakpoint committees in the development of new antifungal agents

    Shawn R. Lockhart, Atlanta, United States

    07 September 2018

    Relevance:

     

    67%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Lisbon, Portugal
    Conference lecture

    New Antibacterial Agents & Stewardship

17. Metallobetalactamases (Epidemiology, Drug Design, Diagnosis and Treatment)

    Sara Boyd, Liverpool, United Kingdom

    06 September 2018

    Relevance:

     

    66%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Lisbon, Portugal
    Conference lecture

    New Antibacterial Agents & Stewardship

18. Old Drug/New Formulation for Europe: Minocycline

    Jeffery Loutit, San Diego, United States

    06 September 2017

    Relevance:

     

    66%

     

    

    Event: ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Boston, United States
    Conference lecture

    Bacterial Susceptibility & Resistance

19. Developing drugs in combination

    Michael Dudley, San Diego, CA, United States

    21 September 2016

    Relevance:

     

    65%

     

    No material available

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

20. The role of breakpoint committees in the development of new antibacterial agents - US perspective

    Jean Patel, Atlanta, United States

    07 September 2018

    Relevance:

     

    65%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Lisbon, Portugal
    Conference lecture

    New Antibacterial Agents & Stewardship